Sean M. Clayton - Net Worth and Insider Trading
Sean M. Clayton Net Worth
The estimated net worth of Sean M. Clayton is at least $86,644 dollars as of 2024-04-16. Sean M. Clayton is the EVP, General Counsel of Horizon Therapeutics PLC and owns about 745 shares of Horizon Therapeutics PLC (HZNP) stock worth over $86,644. Details can be seen in Sean M. Clayton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sean M. Clayton has not made any transactions after 2022-08-04 and currently still holds the listed stock(s).
Transaction Summary of Sean M. Clayton
Sean M. Clayton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sean M. Clayton owns 1 companies in total, including Horizon Therapeutics PLC (HZNP) .
Click here to see the complete history of Sean M. Clayton’s form 4 insider trades.
Insider Ownership Summary of Sean M. Clayton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2022-08-04 | EVP & General Counsel |
Sean M. Clayton Latest Holdings Summary
Sean M. Clayton currently owns a total of 1 stock. Sean M. Clayton owns 745 shares of Horizon Therapeutics PLC (HZNP) as of August 4, 2022, with a value of $86,644.
Latest Holdings of Sean M. Clayton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2022-08-04 | 745 | 116.30 | 86,644 |
Holding Weightings of Sean M. Clayton
Sean M. Clayton Form 4 Trading Tracker
According to the SEC Form 4 filings, Sean M. Clayton has made a total of 1 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Horizon Therapeutics PLC is the acquisition of 745 shares on August 4, 2022, which cost Sean M. Clayton around $49,669.
Insider Trading History of Sean M. Clayton
- 1
Sean M. Clayton Trading Performance
GuruFocus tracks the stock performance after each of Sean M. Clayton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sean M. Clayton is 15.13%. GuruFocus also compares Sean M. Clayton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sean M. Clayton within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sean M. Clayton's insider trading performs compared to the benchmark.
Performance of Sean M. Clayton
Average Relative Return
49.45%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | -10.45 | 15.13 | 63.7 | 49.45 | ||
| Relative Return to S&P 500(%) | -4.97 | 24.32 | 64.07 | 41.6 |
Sean M. Clayton Ownership Network
Ownership Network List of Sean M. Clayton
Ownership Network Relation of Sean M. Clayton
Sean M. Clayton Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
Sean M. Clayton is the EVP & General Counsel of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
Over the past 18 months, Sean M. Clayton made no insider transaction in Horizon Therapeutics PLC (HZNP). Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 40,275 shares made by Jeffrey W Sherman , a net sale of 57,298 shares made by Andy Pasternak , and a net sale of 36,148 shares made by Aaron Cox .
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,721 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,721 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
Sean M. Clayton Mailing Address
Above is the net worth, insider trading, and ownership report for Sean M. Clayton. You might contact Sean M. Clayton via mailing address: C/o Horizon Therapeutics Plc, 70 Saint Stephens Green, Dublin L2 D02 E2x4.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
